3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
23
INDUSTRY
22
FED
3
INDIV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Advanced Solid Cancer
1
Adenocarcinoma
1
Interventions
sargramostim
1
pembrolizumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDIV
×
Prostatic Neoplasms
×
pembrolizumab
×
Clear all
NCT03695835
2020-07-22
NIRPA
Gary Onik MD
Completed
27 enrolled